Navigation Links
Ridge Diagnostics Wins Growth-Promoting Loan From Biotech Center
Date:7/10/2009

RESEARCH TRIANGLE PARK, N.C., July 10 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company with a first-in-class, proprietary blood test for Major Depressive Disorder (MDD), announced the award of a $202,500 loan from the North Carolina Biotechnology Center. The funds will further develop the company's CLIA certified laboratory in Research Triangle Park, thereby supporting the commercialization of its proprietary blood test for depression.

The award was made under the Biotechnology Center's Strategic Growth Loan (SGL) program, which helps promising North Carolina companies succeed in the challenging startup process.

"Ridge Diagnostics is a great example of why the loans from the North Carolina Biotechnology Center are so important," said John Richert, vice president for business and technology development at the North Carolina Biotechnology Center. "By helping them advance their technologies, we enable a strong company to grow stronger, bringing economic opportunity and the prospect of new jobs to the state."

This is the second SGL awarded to Ridge. The company is preparing to launch its multi-analyte blood test for diagnosing clinical depression and monitoring its therapy. The MDDScore(TM) provides objective, biological information associated with physiological changes caused by the condition. The test will be used by physicians to augment traditional diagnostic tools such as behavioral questionnaires and clinical assessments.

"Ridge Diagnostics, once again, would like to thank the NC Biotechnology Center for their ongoing support of the company," said Stan Sewitch, CEO. "By preparing our laboratory for commercial expansion, this Strategic Growth Loan allows us to offer our Clinical Experience Program to physicians and patients in North Carolina and other select areas of the United States."

The Ridge Clinical Experience Program, slated to begin in September, will enable practicing physicians to experience the benefits of the test as an aid in the diagnosis and management of patients with depression.

Ridge Diagnostics, Inc. is a neurodiagnostic company commercializing a breakthrough first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The company's products are based on a proprietary Human Biomarker Library and Hyper-Mapping(TM) analytical technology. Ridge intends to develop a comprehensive program of neuropsychiatric disease diagnostics. Ridge Diagnostics' tests are provided through its CLIA certified laboratory in North Carolina, with plans for diagnostic test kits sold worldwide. The company's research and clinical laboratories are headquartered in Research Triangle Park, NC, with administrative offices in San Diego, CA. www.RidgeDx.com

About the North Carolina Biotechnology Center

The Biotechnology Center, headquartered in Research Triangle Park, is a private, non-profit corporation supported by the NC General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.


'/>"/>
SOURCE Ridge Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
2. Massachusetts Employers and Health Plans Continue to Support Quality Care by Rewarding Physicians through Bridges to Excellence Programs
3. EPA Says Follow-Up Sampling Shows No PCB Risk at Park Ridge Elementary School
4. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
5. The Cambridge Group Names Two New Principals
6. Story tips from the Department of Energys Oak Ridge National Laboratory, Nov. 2007
7. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
8. Bridges to Excellence Announces New Implementation Programs for Health Plans and Additions to Board of Directors
9. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
10. Breckenridge Pharmaceutical Signs Long Term Agreement with Helm AG (Hamburg, Germany)
11. Breckenridge Pharmaceutical Settles Paragraph IV Litigation and Receives FDA Approval for its Oxcarbazepine ANDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is ... than filling out a survey; in many cases health professionals and patients are working ... and research on the importance of active engagement with patients and members of the ...
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading Health ... technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing ... form that can be easily incorporated into liquid products, while reducing costs to end ...
(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance that ... insurance companies have a waiver for care if the client has a cognitive impairment ... family pays for care, is often waived, so the benefits from their insurance start ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “America On The ... identity. “America On The Brink” is the creation of published author, William Nowers. ... great-grandchildren. As a WWII veteran, he spent thirty years in the Navy. ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 West ... in innovative solutions for injectable drug administration, today announced ... the market opens on Thursday, October 26, 2017, and ... results and business expectations at 9:00 a.m. Eastern Time. ... or 253-336-8738 (International). The conference ID is 94093362. ...
(Date:10/11/2017)... , Oct. 11, 2017  True Health, ... has amplified its effort during National Breast Cancer ... hereditary cancer risks. ... Clinical Oncology calculated that more than 10 million ... inherited mutations in BRCA1 or BRCA2 and have not ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
Breaking Medicine Technology: